Trademark Search  /  X

X

● Live · Pending

U.S. federal trademark · Serial No. 97539827

Mark
X
Status
Pending
Serial Number
97539827
Filing Date
August 8, 2022
Class(es)
Class 001, Class 005, Class 040, Class 042

Owners

Elsie Biotechnologies Inc.
03 · San Diego, CA, US
Elsie Biotechnologies Inc.
03 · San Diego, CA, US

Goods & Services

Research and development of oligonucleotide compounds for use in pharmaceutical therapies; Research and development of oligonucleotide delivery agents for use in pharmaceutical therapies; Research and development of oligonucleotide-based or -derived pharmaceuticals; Research and development of pharmaceuticals comprised of oligonucleotide compounds; Research and development of oligonucleotide delivery agents consisting of compounds that facilitate the delivery of a wide range of pharmaceutical and therapeutic agents; Research and development of drug delivery agents consisting of oligonucleotide compounds

Oligonucleotide compounds for use as pharmaceutical therapies for the treatment of a wide variety of conditions and illnesses; Oligonucleotide delivery agents that facilitate delivery of a wide range of pharmaceutical therapies; Oligonucleotide-based or -derived pharmaceuticals for the treatment of a wide variety of conditions and illnesses; Pharmaceuticals comprised of oligonucleotide compounds for the treatment of a wide variety of conditions and illnesses ; Oligonucleotide delivery agents consisting of compounds that facilitate the delivery of a wide range of pharmaceutical and therapeutic agents; Drug delivery agents consisting of oligonucleotide compounds that facilitate delivery of a wide range of pharmaceuticals

Oligonucleotide compounds for use in the manufacture of pharmaceutical therapies

Custom manufacture of oligonucleotides

Thinking of using a similar name?
Search 14 million+ trademarks free and see if your brand conflicts with "X" or anything like it, before you file.
Run a free trademark search →

Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.